An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology:
Biotechnology, a branch of science and a fast-growing source of developing technologies, has shown immense potential for its utility across all the dimensions of our lives. Its applications range from drugs and therapeutics, industrial, household applications, biofuels, and information technology to...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Minneapolis
Bentham Science Publishers
2023
|
| Ausgabe: | 1st ed |
| Online-Zugang: | HWR01 |
| Zusammenfassung: | Biotechnology, a branch of science and a fast-growing source of developing technologies, has shown immense potential for its utility across all the dimensions of our lives. Its applications range from drugs and therapeutics, industrial, household applications, biofuels, and information technology to almost all resource-based sectors, such as manufacturing, aquaculture, agriculture, and forestry. Biotechnology offers outstanding potential to meet the growing demand for food and energy production in a sustainable way. Recognizing its economic and strategic value, countries have implemented several measures to generate a homegrown biotechnology sector and help science-based companies develop. This book covers some of the most important legal issues arising in relation to biotechnology. Topics covered in chapters include 1) the historical development of a legal framework sufficient to protect public safety, 2) the current biotechnology regulatory system and the rules directing the primary agencies that regulate the products of biotechnology (namely the FDA, USDA and EPA), 3) the regulation of human genome editing and its impact on health research, 4) law and emerging genome editing technologies from recombinant DNA technology to CRISPR/Cas9 editing, 5) the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and 6) legal issues arising from the use of genetic engineered plants and animals. The authors have ensured that the contents are easy to understand, making this an accessible reference for a broad range of readers. This book, therefore, serves as a quick summary of the prominent legal and regulatory issues in the biotech industry for professionals, as well as scholars in legal study programs |
| Beschreibung: | Description based on publisher supplied metadata and other sources |
| Beschreibung: | 1 Online-Ressource (165 Seiten) |
| ISBN: | 9789815080629 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048921962 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230502s2023 |||| o||u| ||||||eng d | ||
| 020 | |a 9789815080629 |9 978-981-5080-62-9 | ||
| 035 | |a (ZDB-30-PQE)EBC30377307 | ||
| 035 | |a (ZDB-30-PAD)EBC30377307 | ||
| 035 | |a (ZDB-89-EBL)EBL30377307 | ||
| 035 | |a (OCoLC)1370494182 | ||
| 035 | |a (DE-599)BVBBV048921962 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-2070s | ||
| 100 | 1 | |a Stasi, Alessandro |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| 250 | |a 1st ed | ||
| 264 | 1 | |a Minneapolis |b Bentham Science Publishers |c 2023 | |
| 264 | 4 | |c ©2023 | |
| 300 | |a 1 Online-Ressource (165 Seiten) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on publisher supplied metadata and other sources | ||
| 505 | 8 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKOWNOLEDGEMENTS -- The History of Biotechnology and the Law -- INTRODUCTION -- THE RISE OF MODERN MEDICINE -- THE GREAT AMERICAN FRAUD -- THE POISON SQUAD AND THE LEGISLATIVE HISTORY OF THE PURE FOOD AND DRUGS ACT -- THE DISASTER THAT SHAPED THE FDA -- CONCLUDING REMARKS -- REFERENCES -- The Regulatory Framework -- INTRODUCTION -- AN OVERVIEW OF THE FEDERAL REGULATIONS -- FOOD AND DRUG ADMINISTRATION -- DEPARTMENT OF AGRICULTURE -- ENVIRONMENTAL PROTECTION AGENCY -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Human Genome Editing -- INTRODUCTION -- COMPETING FOR THE HUMAN GROWTH HORMONE -- THE HUMAN GENOME PROJECT -- THE LEGAL ISSUES OF GENE PATENTING -- GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS -- CONCLUDING REMARKS -- REFERENCES -- Law and Emerging Genome Editing Technologies -- INTRODUCTION -- FROM RECOMBINANT DNA TO NEW GENOME EDITING TECHNOLOGIES -- THE FIRST CRISPR PATENT -- Interestingly, the patent also states: -- The patent describes the invention as follows: -- Nucleic Acids -- DNA-Targeting RNA -- DNA-Targeting Segment of a DNA-Targeting RNA -- Protein-Binding Segment of a DNA-Targeting RNA -- Regarding the Utility Criteria, the Patent States: -- PATENT BATTLE, SCIENTIFIC PROGRESS AND THE OBVIOUSNESS TEST -- COURT RULING ON CRISPR GENE EDITING TECHNOLOGIES -- Reasonable Expectation of Success -- Specific Instructions -- Treatment of Simultaneous Invention Evidence -- CONCLUDING REMARKS -- REFERENCES -- Biotechnology, Property and The Human Body -- INTRODUCTION -- DEAD BODY -- LIVING BODIES AND SEPARATED BIOLOGICAL MATERIALS -- Unique T-Lymphocyte Line and Products Derived Therefrom -- Abstract -- Unique T-Lymphocyte Line and Products Derived Therefrom | |
| 505 | 8 | |a Field of the Invention -- Brief Description of the Prior Art -- SUMMARY OF THE INVENTION -- Case History -- EXPERIMENTAL PROCEDURES -- PATENTING HUMAN GENETIC MATERIAL: THE UNUSUAL CASE OF JOHN MOORE -- Introduction -- Facts -- Discussion -- Breach of Fiduciary Duty and Lack of Informed Consent -- Moore's Claim Under Existing Law -- Should Conversion Liability Be Extended? -- Disposition -- PATIENTS TISSUE AND THE IMMORTAL HERITAGE OF HENRIETTA LACKS -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Genetically Engineered Plants and Animals -- INTRODUCTION -- POLICY ISSUES IN GENETICALLY ENGINEERED ANIMALS -- FDA STATUTORY AND REGULATORY AUTHORITY -- ANIMALS WITH INTENTIONALLY ALTERED GENOMIC DNA -- GENETICALLY MODIFIED FOOD -- FOOD POLICY LAWSUITS -- BACKGROUND -- DISCUSSION -- Subject Matter Jurisdiction -- Notice and Comment -- NEPA -- GRAS Presumption -- Labeling -- CONCLUDING REMARKS -- REFERENCES -- Subject Index -- Back Cover | |
| 520 | |a Biotechnology, a branch of science and a fast-growing source of developing technologies, has shown immense potential for its utility across all the dimensions of our lives. Its applications range from drugs and therapeutics, industrial, household applications, biofuels, and information technology to almost all resource-based sectors, such as manufacturing, aquaculture, agriculture, and forestry. Biotechnology offers outstanding potential to meet the growing demand for food and energy production in a sustainable way. Recognizing its economic and strategic value, countries have implemented several measures to generate a homegrown biotechnology sector and help science-based companies develop. This book covers some of the most important legal issues arising in relation to biotechnology. Topics covered in chapters include 1) the historical development of a legal framework sufficient to protect public safety, 2) the current biotechnology regulatory system and the rules directing the primary agencies that regulate the products of biotechnology (namely the FDA, USDA and EPA), 3) the regulation of human genome editing and its impact on health research, 4) law and emerging genome editing technologies from recombinant DNA technology to CRISPR/Cas9 editing, 5) the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and 6) legal issues arising from the use of genetic engineered plants and animals. The authors have ensured that the contents are easy to understand, making this an accessible reference for a broad range of readers. This book, therefore, serves as a quick summary of the prominent legal and regulatory issues in the biotech industry for professionals, as well as scholars in legal study programs | ||
| 700 | 1 | |a Chiang, Tan Weng |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Stasi, Alessandro |t An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |d Minneapolis : Bentham Science Publishers,c2023 |z 9789815080636 |
| 912 | |a ZDB-30-PQE | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034186053 | ||
| 966 | e | |u https://ebookcentral.proquest.com/lib/hwr/detail.action?docID=30377307 |l HWR01 |p ZDB-30-PQE |q HWR_PDA_PQE |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804185104419913728 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Stasi, Alessandro |
| author_facet | Stasi, Alessandro |
| author_role | aut |
| author_sort | Stasi, Alessandro |
| author_variant | a s as |
| building | Verbundindex |
| bvnumber | BV048921962 |
| collection | ZDB-30-PQE |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKOWNOLEDGEMENTS -- The History of Biotechnology and the Law -- INTRODUCTION -- THE RISE OF MODERN MEDICINE -- THE GREAT AMERICAN FRAUD -- THE POISON SQUAD AND THE LEGISLATIVE HISTORY OF THE PURE FOOD AND DRUGS ACT -- THE DISASTER THAT SHAPED THE FDA -- CONCLUDING REMARKS -- REFERENCES -- The Regulatory Framework -- INTRODUCTION -- AN OVERVIEW OF THE FEDERAL REGULATIONS -- FOOD AND DRUG ADMINISTRATION -- DEPARTMENT OF AGRICULTURE -- ENVIRONMENTAL PROTECTION AGENCY -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Human Genome Editing -- INTRODUCTION -- COMPETING FOR THE HUMAN GROWTH HORMONE -- THE HUMAN GENOME PROJECT -- THE LEGAL ISSUES OF GENE PATENTING -- GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS -- CONCLUDING REMARKS -- REFERENCES -- Law and Emerging Genome Editing Technologies -- INTRODUCTION -- FROM RECOMBINANT DNA TO NEW GENOME EDITING TECHNOLOGIES -- THE FIRST CRISPR PATENT -- Interestingly, the patent also states: -- The patent describes the invention as follows: -- Nucleic Acids -- DNA-Targeting RNA -- DNA-Targeting Segment of a DNA-Targeting RNA -- Protein-Binding Segment of a DNA-Targeting RNA -- Regarding the Utility Criteria, the Patent States: -- PATENT BATTLE, SCIENTIFIC PROGRESS AND THE OBVIOUSNESS TEST -- COURT RULING ON CRISPR GENE EDITING TECHNOLOGIES -- Reasonable Expectation of Success -- Specific Instructions -- Treatment of Simultaneous Invention Evidence -- CONCLUDING REMARKS -- REFERENCES -- Biotechnology, Property and The Human Body -- INTRODUCTION -- DEAD BODY -- LIVING BODIES AND SEPARATED BIOLOGICAL MATERIALS -- Unique T-Lymphocyte Line and Products Derived Therefrom -- Abstract -- Unique T-Lymphocyte Line and Products Derived Therefrom Field of the Invention -- Brief Description of the Prior Art -- SUMMARY OF THE INVENTION -- Case History -- EXPERIMENTAL PROCEDURES -- PATENTING HUMAN GENETIC MATERIAL: THE UNUSUAL CASE OF JOHN MOORE -- Introduction -- Facts -- Discussion -- Breach of Fiduciary Duty and Lack of Informed Consent -- Moore's Claim Under Existing Law -- Should Conversion Liability Be Extended? -- Disposition -- PATIENTS TISSUE AND THE IMMORTAL HERITAGE OF HENRIETTA LACKS -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Genetically Engineered Plants and Animals -- INTRODUCTION -- POLICY ISSUES IN GENETICALLY ENGINEERED ANIMALS -- FDA STATUTORY AND REGULATORY AUTHORITY -- ANIMALS WITH INTENTIONALLY ALTERED GENOMIC DNA -- GENETICALLY MODIFIED FOOD -- FOOD POLICY LAWSUITS -- BACKGROUND -- DISCUSSION -- Subject Matter Jurisdiction -- Notice and Comment -- NEPA -- GRAS Presumption -- Labeling -- CONCLUDING REMARKS -- REFERENCES -- Subject Index -- Back Cover |
| ctrlnum | (ZDB-30-PQE)EBC30377307 (ZDB-30-PAD)EBC30377307 (ZDB-89-EBL)EBL30377307 (OCoLC)1370494182 (DE-599)BVBBV048921962 |
| edition | 1st ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06209nmm a2200409zc 4500</leader><controlfield tag="001">BV048921962</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230502s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789815080629</subfield><subfield code="9">978-981-5080-62-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PQE)EBC30377307</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC30377307</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL30377307</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1370494182</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048921962</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-2070s</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stasi, Alessandro</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Minneapolis</subfield><subfield code="b">Bentham Science Publishers</subfield><subfield code="c">2023</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (165 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKOWNOLEDGEMENTS -- The History of Biotechnology and the Law -- INTRODUCTION -- THE RISE OF MODERN MEDICINE -- THE GREAT AMERICAN FRAUD -- THE POISON SQUAD AND THE LEGISLATIVE HISTORY OF THE PURE FOOD AND DRUGS ACT -- THE DISASTER THAT SHAPED THE FDA -- CONCLUDING REMARKS -- REFERENCES -- The Regulatory Framework -- INTRODUCTION -- AN OVERVIEW OF THE FEDERAL REGULATIONS -- FOOD AND DRUG ADMINISTRATION -- DEPARTMENT OF AGRICULTURE -- ENVIRONMENTAL PROTECTION AGENCY -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Human Genome Editing -- INTRODUCTION -- COMPETING FOR THE HUMAN GROWTH HORMONE -- THE HUMAN GENOME PROJECT -- THE LEGAL ISSUES OF GENE PATENTING -- GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS -- CONCLUDING REMARKS -- REFERENCES -- Law and Emerging Genome Editing Technologies -- INTRODUCTION -- FROM RECOMBINANT DNA TO NEW GENOME EDITING TECHNOLOGIES -- THE FIRST CRISPR PATENT -- Interestingly, the patent also states: -- The patent describes the invention as follows: -- Nucleic Acids -- DNA-Targeting RNA -- DNA-Targeting Segment of a DNA-Targeting RNA -- Protein-Binding Segment of a DNA-Targeting RNA -- Regarding the Utility Criteria, the Patent States: -- PATENT BATTLE, SCIENTIFIC PROGRESS AND THE OBVIOUSNESS TEST -- COURT RULING ON CRISPR GENE EDITING TECHNOLOGIES -- Reasonable Expectation of Success -- Specific Instructions -- Treatment of Simultaneous Invention Evidence -- CONCLUDING REMARKS -- REFERENCES -- Biotechnology, Property and The Human Body -- INTRODUCTION -- DEAD BODY -- LIVING BODIES AND SEPARATED BIOLOGICAL MATERIALS -- Unique T-Lymphocyte Line and Products Derived Therefrom -- Abstract -- Unique T-Lymphocyte Line and Products Derived Therefrom</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Field of the Invention -- Brief Description of the Prior Art -- SUMMARY OF THE INVENTION -- Case History -- EXPERIMENTAL PROCEDURES -- PATENTING HUMAN GENETIC MATERIAL: THE UNUSUAL CASE OF JOHN MOORE -- Introduction -- Facts -- Discussion -- Breach of Fiduciary Duty and Lack of Informed Consent -- Moore's Claim Under Existing Law -- Should Conversion Liability Be Extended? -- Disposition -- PATIENTS TISSUE AND THE IMMORTAL HERITAGE OF HENRIETTA LACKS -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Genetically Engineered Plants and Animals -- INTRODUCTION -- POLICY ISSUES IN GENETICALLY ENGINEERED ANIMALS -- FDA STATUTORY AND REGULATORY AUTHORITY -- ANIMALS WITH INTENTIONALLY ALTERED GENOMIC DNA -- GENETICALLY MODIFIED FOOD -- FOOD POLICY LAWSUITS -- BACKGROUND -- DISCUSSION -- Subject Matter Jurisdiction -- Notice and Comment -- NEPA -- GRAS Presumption -- Labeling -- CONCLUDING REMARKS -- REFERENCES -- Subject Index -- Back Cover</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Biotechnology, a branch of science and a fast-growing source of developing technologies, has shown immense potential for its utility across all the dimensions of our lives. Its applications range from drugs and therapeutics, industrial, household applications, biofuels, and information technology to almost all resource-based sectors, such as manufacturing, aquaculture, agriculture, and forestry. Biotechnology offers outstanding potential to meet the growing demand for food and energy production in a sustainable way. Recognizing its economic and strategic value, countries have implemented several measures to generate a homegrown biotechnology sector and help science-based companies develop. This book covers some of the most important legal issues arising in relation to biotechnology. Topics covered in chapters include 1) the historical development of a legal framework sufficient to protect public safety, 2) the current biotechnology regulatory system and the rules directing the primary agencies that regulate the products of biotechnology (namely the FDA, USDA and EPA), 3) the regulation of human genome editing and its impact on health research, 4) law and emerging genome editing technologies from recombinant DNA technology to CRISPR/Cas9 editing, 5) the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and 6) legal issues arising from the use of genetic engineered plants and animals. The authors have ensured that the contents are easy to understand, making this an accessible reference for a broad range of readers. This book, therefore, serves as a quick summary of the prominent legal and regulatory issues in the biotech industry for professionals, as well as scholars in legal study programs</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chiang, Tan Weng</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Stasi, Alessandro</subfield><subfield code="t">An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology</subfield><subfield code="d">Minneapolis : Bentham Science Publishers,c2023</subfield><subfield code="z">9789815080636</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PQE</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034186053</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://ebookcentral.proquest.com/lib/hwr/detail.action?docID=30377307</subfield><subfield code="l">HWR01</subfield><subfield code="p">ZDB-30-PQE</subfield><subfield code="q">HWR_PDA_PQE</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048921962 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:55:17Z |
| indexdate | 2024-07-10T09:49:56Z |
| institution | BVB |
| isbn | 9789815080629 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034186053 |
| oclc_num | 1370494182 |
| open_access_boolean | |
| owner | DE-2070s |
| owner_facet | DE-2070s |
| physical | 1 Online-Ressource (165 Seiten) |
| psigel | ZDB-30-PQE ZDB-30-PQE HWR_PDA_PQE |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Bentham Science Publishers |
| record_format | marc |
| spelling | Stasi, Alessandro Verfasser aut An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology 1st ed Minneapolis Bentham Science Publishers 2023 ©2023 1 Online-Ressource (165 Seiten) txt rdacontent c rdamedia cr rdacarrier Description based on publisher supplied metadata and other sources Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKOWNOLEDGEMENTS -- The History of Biotechnology and the Law -- INTRODUCTION -- THE RISE OF MODERN MEDICINE -- THE GREAT AMERICAN FRAUD -- THE POISON SQUAD AND THE LEGISLATIVE HISTORY OF THE PURE FOOD AND DRUGS ACT -- THE DISASTER THAT SHAPED THE FDA -- CONCLUDING REMARKS -- REFERENCES -- The Regulatory Framework -- INTRODUCTION -- AN OVERVIEW OF THE FEDERAL REGULATIONS -- FOOD AND DRUG ADMINISTRATION -- DEPARTMENT OF AGRICULTURE -- ENVIRONMENTAL PROTECTION AGENCY -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Human Genome Editing -- INTRODUCTION -- COMPETING FOR THE HUMAN GROWTH HORMONE -- THE HUMAN GENOME PROJECT -- THE LEGAL ISSUES OF GENE PATENTING -- GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS -- CONCLUDING REMARKS -- REFERENCES -- Law and Emerging Genome Editing Technologies -- INTRODUCTION -- FROM RECOMBINANT DNA TO NEW GENOME EDITING TECHNOLOGIES -- THE FIRST CRISPR PATENT -- Interestingly, the patent also states: -- The patent describes the invention as follows: -- Nucleic Acids -- DNA-Targeting RNA -- DNA-Targeting Segment of a DNA-Targeting RNA -- Protein-Binding Segment of a DNA-Targeting RNA -- Regarding the Utility Criteria, the Patent States: -- PATENT BATTLE, SCIENTIFIC PROGRESS AND THE OBVIOUSNESS TEST -- COURT RULING ON CRISPR GENE EDITING TECHNOLOGIES -- Reasonable Expectation of Success -- Specific Instructions -- Treatment of Simultaneous Invention Evidence -- CONCLUDING REMARKS -- REFERENCES -- Biotechnology, Property and The Human Body -- INTRODUCTION -- DEAD BODY -- LIVING BODIES AND SEPARATED BIOLOGICAL MATERIALS -- Unique T-Lymphocyte Line and Products Derived Therefrom -- Abstract -- Unique T-Lymphocyte Line and Products Derived Therefrom Field of the Invention -- Brief Description of the Prior Art -- SUMMARY OF THE INVENTION -- Case History -- EXPERIMENTAL PROCEDURES -- PATENTING HUMAN GENETIC MATERIAL: THE UNUSUAL CASE OF JOHN MOORE -- Introduction -- Facts -- Discussion -- Breach of Fiduciary Duty and Lack of Informed Consent -- Moore's Claim Under Existing Law -- Should Conversion Liability Be Extended? -- Disposition -- PATIENTS TISSUE AND THE IMMORTAL HERITAGE OF HENRIETTA LACKS -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Genetically Engineered Plants and Animals -- INTRODUCTION -- POLICY ISSUES IN GENETICALLY ENGINEERED ANIMALS -- FDA STATUTORY AND REGULATORY AUTHORITY -- ANIMALS WITH INTENTIONALLY ALTERED GENOMIC DNA -- GENETICALLY MODIFIED FOOD -- FOOD POLICY LAWSUITS -- BACKGROUND -- DISCUSSION -- Subject Matter Jurisdiction -- Notice and Comment -- NEPA -- GRAS Presumption -- Labeling -- CONCLUDING REMARKS -- REFERENCES -- Subject Index -- Back Cover Biotechnology, a branch of science and a fast-growing source of developing technologies, has shown immense potential for its utility across all the dimensions of our lives. Its applications range from drugs and therapeutics, industrial, household applications, biofuels, and information technology to almost all resource-based sectors, such as manufacturing, aquaculture, agriculture, and forestry. Biotechnology offers outstanding potential to meet the growing demand for food and energy production in a sustainable way. Recognizing its economic and strategic value, countries have implemented several measures to generate a homegrown biotechnology sector and help science-based companies develop. This book covers some of the most important legal issues arising in relation to biotechnology. Topics covered in chapters include 1) the historical development of a legal framework sufficient to protect public safety, 2) the current biotechnology regulatory system and the rules directing the primary agencies that regulate the products of biotechnology (namely the FDA, USDA and EPA), 3) the regulation of human genome editing and its impact on health research, 4) law and emerging genome editing technologies from recombinant DNA technology to CRISPR/Cas9 editing, 5) the development of legal principles to protect property rights in the human body and allow the efficient use of human tissue, organs, DNA, and cell-lines in medical research, and 6) legal issues arising from the use of genetic engineered plants and animals. The authors have ensured that the contents are easy to understand, making this an accessible reference for a broad range of readers. This book, therefore, serves as a quick summary of the prominent legal and regulatory issues in the biotech industry for professionals, as well as scholars in legal study programs Chiang, Tan Weng Sonstige oth Erscheint auch als Druck-Ausgabe Stasi, Alessandro An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology Minneapolis : Bentham Science Publishers,c2023 9789815080636 |
| spellingShingle | Stasi, Alessandro An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKOWNOLEDGEMENTS -- The History of Biotechnology and the Law -- INTRODUCTION -- THE RISE OF MODERN MEDICINE -- THE GREAT AMERICAN FRAUD -- THE POISON SQUAD AND THE LEGISLATIVE HISTORY OF THE PURE FOOD AND DRUGS ACT -- THE DISASTER THAT SHAPED THE FDA -- CONCLUDING REMARKS -- REFERENCES -- The Regulatory Framework -- INTRODUCTION -- AN OVERVIEW OF THE FEDERAL REGULATIONS -- FOOD AND DRUG ADMINISTRATION -- DEPARTMENT OF AGRICULTURE -- ENVIRONMENTAL PROTECTION AGENCY -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Human Genome Editing -- INTRODUCTION -- COMPETING FOR THE HUMAN GROWTH HORMONE -- THE HUMAN GENOME PROJECT -- THE LEGAL ISSUES OF GENE PATENTING -- GENE PATENTS IN THE WAKE OF ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS -- CONCLUDING REMARKS -- REFERENCES -- Law and Emerging Genome Editing Technologies -- INTRODUCTION -- FROM RECOMBINANT DNA TO NEW GENOME EDITING TECHNOLOGIES -- THE FIRST CRISPR PATENT -- Interestingly, the patent also states: -- The patent describes the invention as follows: -- Nucleic Acids -- DNA-Targeting RNA -- DNA-Targeting Segment of a DNA-Targeting RNA -- Protein-Binding Segment of a DNA-Targeting RNA -- Regarding the Utility Criteria, the Patent States: -- PATENT BATTLE, SCIENTIFIC PROGRESS AND THE OBVIOUSNESS TEST -- COURT RULING ON CRISPR GENE EDITING TECHNOLOGIES -- Reasonable Expectation of Success -- Specific Instructions -- Treatment of Simultaneous Invention Evidence -- CONCLUDING REMARKS -- REFERENCES -- Biotechnology, Property and The Human Body -- INTRODUCTION -- DEAD BODY -- LIVING BODIES AND SEPARATED BIOLOGICAL MATERIALS -- Unique T-Lymphocyte Line and Products Derived Therefrom -- Abstract -- Unique T-Lymphocyte Line and Products Derived Therefrom Field of the Invention -- Brief Description of the Prior Art -- SUMMARY OF THE INVENTION -- Case History -- EXPERIMENTAL PROCEDURES -- PATENTING HUMAN GENETIC MATERIAL: THE UNUSUAL CASE OF JOHN MOORE -- Introduction -- Facts -- Discussion -- Breach of Fiduciary Duty and Lack of Informed Consent -- Moore's Claim Under Existing Law -- Should Conversion Liability Be Extended? -- Disposition -- PATIENTS TISSUE AND THE IMMORTAL HERITAGE OF HENRIETTA LACKS -- CONCLUDING REMARKS -- REFERENCES -- The Regulation of Genetically Engineered Plants and Animals -- INTRODUCTION -- POLICY ISSUES IN GENETICALLY ENGINEERED ANIMALS -- FDA STATUTORY AND REGULATORY AUTHORITY -- ANIMALS WITH INTENTIONALLY ALTERED GENOMIC DNA -- GENETICALLY MODIFIED FOOD -- FOOD POLICY LAWSUITS -- BACKGROUND -- DISCUSSION -- Subject Matter Jurisdiction -- Notice and Comment -- NEPA -- GRAS Presumption -- Labeling -- CONCLUDING REMARKS -- REFERENCES -- Subject Index -- Back Cover |
| title | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_auth | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_exact_search | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_exact_search_txtP | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_full | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_fullStr | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_full_unstemmed | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_short | An Introduction to Legal, Regulatory and Intellectual Property Rights Issues in Biotechnology |
| title_sort | an introduction to legal regulatory and intellectual property rights issues in biotechnology |
| work_keys_str_mv | AT stasialessandro anintroductiontolegalregulatoryandintellectualpropertyrightsissuesinbiotechnology AT chiangtanweng anintroductiontolegalregulatoryandintellectualpropertyrightsissuesinbiotechnology |